Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Aldeyra Therapeutics Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a 107.90% increase from the last price of 4.81.
High | 149.5% | 12.00 |
Med | 107.9% | 10.00 |
Low | 66.3% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 05, 2025.
Average growth rate | -30.36% |
Average growth rate | +23.65% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼